Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose Ramon Arribas

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of the International AIDS Society|November 14, 2014
Cerebral volumes, neuronal integrity and brain inflammation measured by MRI in patients receiving PI monotherapy or triple therapyIgnacio Pérez Valero, Alicia Gonzalez Baeza, Juan Antonio Hernandez-Tamames, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|January 18, 2016
[Ebola virus disease: Update]Fernando de la Calle-Prieto, Marta Arsuaga-Vicente, Marta Mora-Rillo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 11, 2021
The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysisİlker Kayı, Bahar Madran, Şiran Keske, et al.
American Journal of Public Health|August 21, 2010
Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trialAlan R Lifson, Jacqueline Neuhaus, Jose Ramon Arribas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2011
Hypertension and isolated office hypertension in HIV-infected patients determined by ambulatory blood pressure monitoring: prevalence and risk factorsJose Ignacio Bernardino, Marta Mora, Francisco Xavier Zamora, et al.
Virulence|February 6, 2015
Impact of virulence genes on sepsis severity and survival in Escherichia coli bacteremiaMarta Mora-Rillo, Natalia Fernández-Romero, Carolina Navarro-San Francisco, et al.
Plos One|April 9, 2020
Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1-positive individualsMathieu Chalouni, Javier Rodriguez-Centeno, Assia Samri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2010
Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT studyHans-Jürgen Stellbrink, Chloe Orkin, Jose Ramon Arribas, et al.
Open Forum Infectious Diseases|March 10, 2025
Three-Year Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide as a Switch Strategy in the Real WorldAlejandro de Gea-Grela, Rafael Micán, Rosa de Miguel, et al.
HIV Medicine|August 7, 2025
Morbidity and risk factors of COVID-19 in people with HIV-1 in Europe: A combined observational cohort and nested case-control studyGeorg M N Behrens, Lambert Assoumou, Stephane De Wit, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of the International AIDS Society|November 14, 2014
Cerebral volumes, neuronal integrity and brain inflammation measured by MRI in patients receiving PI monotherapy or triple therapyIgnacio Pérez Valero, Alicia Gonzalez Baeza, Juan Antonio Hernandez-Tamames, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|January 18, 2016
[Ebola virus disease: Update]Fernando de la Calle-Prieto, Marta Arsuaga-Vicente, Marta Mora-Rillo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 11, 2021
The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysisİlker Kayı, Bahar Madran, Şiran Keske, et al.
American Journal of Public Health|August 21, 2010
Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trialAlan R Lifson, Jacqueline Neuhaus, Jose Ramon Arribas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2011
Hypertension and isolated office hypertension in HIV-infected patients determined by ambulatory blood pressure monitoring: prevalence and risk factorsJose Ignacio Bernardino, Marta Mora, Francisco Xavier Zamora, et al.
Virulence|February 6, 2015
Impact of virulence genes on sepsis severity and survival in Escherichia coli bacteremiaMarta Mora-Rillo, Natalia Fernández-Romero, Carolina Navarro-San Francisco, et al.
Plos One|April 9, 2020
Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1-positive individualsMathieu Chalouni, Javier Rodriguez-Centeno, Assia Samri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2010
Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT studyHans-Jürgen Stellbrink, Chloe Orkin, Jose Ramon Arribas, et al.
Open Forum Infectious Diseases|March 10, 2025
Three-Year Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide as a Switch Strategy in the Real WorldAlejandro de Gea-Grela, Rafael Micán, Rosa de Miguel, et al.
HIV Medicine|August 7, 2025
Morbidity and risk factors of COVID-19 in people with HIV-1 in Europe: A combined observational cohort and nested case-control studyGeorg M N Behrens, Lambert Assoumou, Stephane De Wit, et al.
Pageof 2